-
1 Comment
Lotus Health Group Company is currently in a long term uptrend where the price is trading 15.2% above its 200 day moving average.
From a valuation standpoint, the stock is 63.2% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 2.5.
Lotus Health Group Company's total revenue rose by 13.8% to $445M since the same quarter in the previous year.
Its net income has increased by 190.5% to $22M since the same quarter in the previous year.
Finally, its free cash flow fell by 429.3% to $-84M since the same quarter in the previous year.
Based on the above factors, Lotus Health Group Company gets an overall score of 4/5.
Sector | Consumer Defensive |
---|---|
Exchange | SHG |
CurrencyCode | CNY |
ISIN | CNE000000WY0 |
Industry | Packaged Foods |
PE Ratio | 57.36 |
---|---|
Target Price | None |
Market Cap | 11B |
Beta | 0.06 |
Dividend Yield | None |
Lotus Health Group Company engages in the production and sale of condiments and foods in China. The company offers monosodium glutamate; chicken essence and other seasonings; and breadcrumbs and other flour products, as well as sauces, starch, and sugars. It also provides cooking wine and other liquid condiments, flour and pasta products, organic and water soluble fertilizers, sesame oil, brown sugar, gift packs, health packs, and baking soda. The company was formerly known as Lotus Health Industry Holding Group Company. Lotus Health Group Company was founded in 1983 and is based in Zhoukou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600186.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025